Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer

NCT01599182 is registered in ClinicalTrials.gov with University of Waterloo as lead sponsor.

NCT NCT01599182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01599182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer
Lead sponsor
University of Waterloo
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2014
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer